Unique real-world study in diabetic macular oedema (DMO)

SVMPharma has recently collected real-world data in the UK (ICE-UK) and Portugal (ICE-PT) for DMO patients looking at the effectiveness of fluocinolone acetonide intravitreal implant (LUVIEN®). This has led to successful outcomes leading to multiple publications to presentations in a major European congress in 2017 and 2018 Chart notes Treatment data Align with KOLs SVMPharma’s […]

Read More
FINAL RWE39 DESERVE infographic

DESERVE showed significant benefits in NHS healthcare savings

SVMPharma’s real-world evidence helped deliver a real-world study looking at the clinical outcomes of triptorelin vs other LHRH agonists (LHRHa) in clinical practice for prostate cancer patients. Our real-world evidence helped show a significant reduction in healthcare resource utilisation for the NHS as well as maintenance in PSA control (a biomarker in prostate cancer) when switching to a 6-monthly formulation […]

Read More